Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array

被引：25
|
作者：
Zhang, Huakun [1 ,2 ,4 ]
Ma, Haiqing [1 ,2 ]
Wang, Qujing [1 ,2 ]
Chen, Minshan [3 ]
Weng, Desheng [1 ,2 ]
Wang, Hui [1 ,2 ]
Zhou, Jun [1 ,2 ]
Li, Yongqiang [1 ,2 ]
Sun, Jiancong [1 ,2 ]
Chen, Yibing [1 ,2 ]
Liang, Xiaoting [1 ,2 ]
Zhao, Jingjing [1 ,2 ]
Pan, Ke [1 ,2 ]
Wang, Huiyun [1 ,2 ]
Xia, Jianchuan [1 ,2 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobilary Oncol, Guangzhou 510060, Guangdong, Peoples R China
[4] Shenzhen Matern & Child Healthcare Hosp, Cent Lab, Shenzhen 518033, Guangdong, Peoples R China
来源：
ONCOLOGY REPORTS | 2010年 / 23卷 / 02期
关键词：
hepatocellular carcinoma; loss of heterozygosity; single nucleotide polymorphism; tumour suppressor gene; CANDIDATE TUMOR-SUPPRESSOR; SQUAMOUS-CELL CARCINOMA; GENETIC ALTERATIONS; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; PRIMER EXTENSION; FREQUENT LOSS; HOST-DEFENSE; DNA-DAMAGE; REGION;
D O I：
10.3892/or_00000654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
To identify tumour suppressor genes (TSGs) associated with hepatocellular carcinoma (HCC) on chromosome 4q using a high-throughput single nucleotide polymorphism (SNP) array, we first scanned for loss of heterozygosity (LOH) of 40 SNPs on chromosome 4q and discovered 2 hot regions: 4q24-26 and 4q34.3-35. We then further scanned for LOH of 338 SNPs in genes around 4q34.3-35 and discovered 3 genes with the most frequent LOH: nei endonuclease VIII-like 3 (NEIL3), interferon regulatory factor 2 (IRF2) and inhibitor of growth family member 2 (ING2). A review of the literature indicates only ING2 might be a TSG associated with HCC.
引用
收藏
页码：445 / 455
页数：11
相关论文
共 31 条
  • [21] Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma
    Mehri Igci
    Ahmet Arslan
    Sakip Erturhan
    Yusuf Ziya Igci
    Elif Pala
    Bulent Gogebakan
    Metin Karakok
    Ecir Ali Cakmak
    Beyhan Cengiz
    Molecular Biology Reports, 2015, 42 : 507 - 516
  • [22] Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma
    Igci, Mehri
    Arslan, Ahmet
    Erturhan, Sakip
    Igci, Yusuf Ziya
    Pala, Elif
    Gogebakan, Bulent
    Karakok, Metin
    Cakmak, Ecir Ali
    Cengiz, Beyhan
    MOLECULAR BIOLOGY REPORTS, 2015, 42 (02) : 507 - 516
  • [23] A genome-wide analysis of loss of heterozygosity and chromosomal copy number variation in Proteus syndrome using high-density SNP microarrays
    Yilmaz, Ahmet
    Hamel, Nancy
    Schwartz, Charles E.
    Houlston, Richard S.
    Harper, John I.
    Foulkes, William D.
    JOURNAL OF HUMAN GENETICS, 2010, 55 (09) : 627 - 630
  • [24] High-throughput sequencing-based analysis of gene expression of hepatitis B virus infection-associated human hepatocellular carcinoma
    Zeng, Hao
    Hui, Ying
    Qin, Wenzhou
    Chen, Peisheng
    Huang, Lifang
    Zhong, Wenfu
    Lin, Liwen
    Lv, Hui
    Qin, Xue
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [25] A genome-wide analysis of loss of heterozygosity and chromosomal copy number variation in Proteus syndrome using high-density SNP microarrays
    Ahmet Yilmaz
    Nancy Hamel
    Charles E Schwartz
    Richard S Houlston
    John I Harper
    William D Foulkes
    Journal of Human Genetics, 2010, 55 : 627 - 630
  • [26] Genetic aberration in primary hepatocellular carcinoma:correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23
    WANG GANG
    CHANG HUI HUANG
    YAN ZHAO
    LING CAI
    YING WANG
    SHI JIN XIU
    ZHENG WEN JIANG
    SHUANG YANG
    XIN TAI ZHAO
    WEI HUANG
    JIAN REN GU National Laboratory for Oncogene and Related Genes
    CellResearch, 2000, (04) : 311 - 323
  • [27] Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23
    Wang, G
    Huang, CH
    Zhao, Y
    Cai, L
    Wang, Y
    Xiu, SJ
    Jiang, ZW
    Yang, S
    Zhao, XT
    Huang, W
    Gu, JR
    CELL RESEARCH, 2000, 10 (04) : 311 - 323
  • [28] Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array
    Lin, Lian-Jie
    Asaoka, Yoshinari
    Tada, Motohisa
    Sanada, Masashi
    Nannya, Yasuhito
    Tanaka, Yasuo
    Tateishi, Keisuke
    Ohta, Miki
    Seto, Motoko
    Sasahira, Naoki
    Tada, Minoru
    Kawabe, Takao
    Zheng, Chang-Qing
    Kanai, Fumihiko
    Ogawa, Seishi
    Omata, Masao
    ONCOLOGY, 2008, 75 (1-2) : 102 - 112
  • [29] A Broad Range High-Throughput Assay for Lenvatinib Using Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry With Clinical Application in Patients With Hepatocellular Carcinoma
    Sueshige, Yoshio
    Shiraiwa, Ken
    Honda, Koichi
    Tanaka, Ryota
    Saito, Tomoko
    Tokoro, Masanori
    Iwao, Masao
    Endo, Mizuki
    Arakawa, Mie
    Tatsuta, Ryosuke
    Seike, Masataka
    Murakami, Kazunari
    Itoh, Hiroki
    THERAPEUTIC DRUG MONITORING, 2021, 43 (05) : 664 - 671
  • [30] Clinical Value for Diagnosis and Prognosis of Signal Sequence Receptor I (SSR I) and Its Potential Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on High-Throughput Data Analysis
    Chen, Liang
    Lin, Yunhua
    Liu, Guoqing
    Xu, Rubin
    Hu, Yiming
    Xie, Jiaheng
    Yu, Hongzhu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 7435 - 7451
1234